SP

Srilatha Puli

Active Director Director DIN 08603765
DIN 08603765 First appointment Nov 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value •••• Premium profile

About Srilatha Puli

Data last updated:

Srilatha Puli is a Director at Epione Paincare Private Limited (since 2019). The company operates in Healthcare. Epione Paincare Private Limited reported revenue of ₹27.44 Cr (FY 2024).

DIN 08603765
Primary Designation Director
Industry Healthcare
First Appointment 06 Nov 2019
Oldest Company Age 6 yrs
Largest company Epione Paincare Private Limited · ₹27.44 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Epione Paincare Private Limited U85300TG2019PTC136629
Director06 Nov 20192019₹27.44 Cr (FY 2024)Active

Board colleagues of Srilatha Puli

Directorship timeline

Open interactive timeline →
Epione Paincare Private Limited
Premium access

Shareholding and investment profile for Srilatha Puli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srilatha Puli

Srilatha Puli currently holds 1 directorship: Epione Paincare Private Limited (Director, since 06 Nov 2019, revenue ₹27.44 Cr (FY 2024)).

Srilatha Puli was first appointed on 06 Nov 2019 as Director at Epione Paincare Private Limited.

The current boards of Srilatha Puli's companies include Minal Chandra (Epione Paincare Private Limited), Sudheer Dara (Epione Paincare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available